New insights on CETP inhibition from genetic research and clinical trials
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Exploring the role of a novel CETP inhibitor in lipid management
Roxana Mehran, MD
Seeing the forest through the trees - Diagnosing and treating hypertrophic cardiomyopathy
Antonis Pantazis, MD
Pablo García-Pavía, MD, PhD
Carolyn Ho, MD
Hypertrophic cardiomyopathy: What are the concerns?
Diagnostic challenges for symptomatic obstructive HCM
Improving quality of life in patients with HCM
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.